Laidlaw Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Laidlaw Wealth Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $102,323 - $116,384	132 Added 35.01%	509 $447,000
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $38,777 - $47,284	-56 Reduced 12.93%	377 $310,000
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $27,301 - $32,383	-39 Reduced 8.26%	433 $311,000
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $1,411 - $1,532	-2 Reduced 0.42%	472 $340,000
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $19,514 - $24,626	34 Added 7.73%	474 $327,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $1,190 - $1,396	-2 Reduced 0.45%	440 $307,000
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $2,717 - $3,354	5 Added 1.14%	442 $279,000
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $1,722 - $2,042	-3 Reduced 0.68%	437 $264,000
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $208,032 - $245,757	440 New	440 $246,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $192,540 - $236,274	-431 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $4,304 - $5,471	9 Added 2.13%	431 $208,000
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $229,884 - $277,764	422 New	422 $236,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Laidlaw Wealth Management LLC with notifications on news.